Takara Bio Inc. | Income Statement
Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
23,905
25,969
29,729
29,375
32,312
35,841
Cost of Goods Sold (COGS) incl. D&A
11,547
12,450
13,940
12,988
14,233
15,662
Gross Income
12,358
13,519
15,789
16,387
18,079
20,179
SG&A Expense
10,404
11,217
13,122
13,183
14,512
14,714
EBIT
1,954
2,302
2,667
3,204
3,567
5,465
Unusual Expense
-
247
281
667
457
833
Non Operating Income/Expense
114
291
351
164
192
104
Interest Expense
7
11
2
2
19
-
Pretax Income
2,185
2,481
2,905
2,805
3,361
4,823
Income Tax
726
1,522
1,566
1,449
1,023
1,149
Consolidated Net Income
1,459
959
1,339
1,356
2,338
3,673
Net Income
1,470
963
1,334
1,353
2,335
3,658
Net Income After Extraordinaries
1,470
963
1,334
1,353
2,335
3,658
Net Income Available to Common
1,470
963
1,334
1,352
2,335
3,657
EPS (Basic)
12.50
8.00
11.08
11.23
19.39
30.37
Basic Shares Outstanding
118
120
120
120
120
120
EPS (Diluted)
12.45
8.00
11.08
11.23
19.39
30.37
Diluted Shares Outstanding
118
120
120
120
120
120
EBITDA
3,421
3,974
4,734
5,253
6,784
8,840
Non-Operating Interest Income
124
146
170
108
77
89
Minority Interest Expense
11
4
5
3
3
15
About Takara Bio
View Profile
